Physician
Sverkunova, Lyudmila
Sverkunova, Lyudmila was paid $3.38M by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoSVERKUNOVA, LYUDMILA
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1306825567assigned 01/15/2006
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$3.38M
24GClaims122,433
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in New York
Rank by total paid#19 of 161
Median peer was paid$100K
This provider vs. median34×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,065 | $302K | |
| 2019 | 14,672 | $383K | |
| 2020 | 14,776 | $386K | |
| 2021 | 17,653 | $526K | |
| 2022 | 21,716 | $635K | |
| 2023 | 23,165 | $624K | |
| 2024incomplete | 19,386 | $521K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 16,106 | 13,386 | $1.10M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 5,473 | 4,912 | $534K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.7% | 6,240 | 5,793 | $259K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 2,555 | 2,519 | $215K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 2,526 | 2,422 | $194K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.3% | 2,183 | 2,140 | $179K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.2% | 9,816 | 9,546 | $177K |
| 92587 | 4.6% | 5,534 | 5,472 | $154K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.6% | 4,050 | 3,843 | $120K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 1,220 | 1,212 | $111K |
| 99429 | 1.8% | 4,075 | 3,988 | $62K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 2,614 | 2,485 | $49K |
46 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 10,276 | $37K |
| 92568 | 1.1% | 3,178 | $36K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,433 | $33K |
| 81000 | <1% | 6,869 | $21K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,972 | $18K |
| 90461 | <1% | 2,048 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 319 | $12K |
| 94664 | <1% | 1,966 | $10K | |
| 99442 | <1% | 141 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,956 | $7K |
| 90677 | <1% | 85 | $4K | |
| 99443 | <1% | 56 | $4K | |
| 0002A | <1% | 82 | $3K | |
| 90733 | <1% | 305 | $3K | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 1,817 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 207 | $3K |
| 0001A | <1% | 73 | $2K | |
| 83655 | <1% | 226 | $1K | |
| 90670 | <1% | 914 | $1K | |
| 99383 | <1% | 13 | $1K | |
| 0072A | <1% | 32 | $1K | |
| 90671 | <1% | 15 | $916.64 | |
| 0071A | <1% | 20 | $742.45 | |
| 90686 | <1% | 1,675 | $664.39 | |
| 90716 | <1% | 697 | $581.77 | |
| 87807 | <1% | 47 | $448.81 | |
| 92567 | <1% | 200 | $377.29 | |
| 99177 | <1% | 1,979 | $307.42 | |
| 90707 | <1% | 469 | $256.29 | |
| 90656 | <1% | 135 | $168.05 | |
| 92558 | <1% | 62 | $161.31 | |
| 90633 | <1% | 745 | $146.51 | |
| 90744 | <1% | 512 | $129.43 | |
| 86580 | <1% | 12 | $66.06 | |
| 99000 | <1% | 241 | $57.60 | |
| 90715 | <1% | 81 | $54.84 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,205 | $42.25 |
| 90680 | <1% | 280 | $35.70 | |
| 90648 | <1% | 699 | $17.85 | |
| 91307 | <1% | 61 | $0.10 | |
| 91300 | <1% | 81 | $0.06 | |
| 90713 | 0% | 1,061 | $0.00 | |
| 90700 | 0% | 1,477 | $0.00 | |
| 90685 | 0% | 269 | $0.00 | |
| 90698 | 0% | 12 | $0.00 | |
| 90651 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.